AllianzIM U.S. Equity Buffer20 Nov ETF (BATS:NVBW – Get Free Report) was the target of a large drop in short interest in October. As of October 15th, there was short interest totaling 112 shares, a drop of 35.6% from the September 30th total of 174 shares. Based on an average daily trading volume, of 3,346 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.
Institutional Investors Weigh In On AllianzIM U.S. Equity Buffer20 Nov ETF
An institutional investor recently bought a new stake in AllianzIM U.S. Equity Buffer20 Nov ETF stock. Blue Bell Private Wealth Management LLC bought a new stake in shares of AllianzIM U.S. Equity Buffer20 Nov ETF (BATS:NVBW – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,996 shares of the company’s stock, valued at approximately $73,000. Blue Bell Private Wealth Management LLC owned about 0.08% of AllianzIM U.S. Equity Buffer20 Nov ETF as of its most recent filing with the Securities and Exchange Commission.
AllianzIM U.S. Equity Buffer20 Nov ETF Stock Performance
Shares of BATS NVBW opened at $36.92 on Monday. The firm’s 50-day moving average price is $36.61 and its 200-day moving average price is $35.25. The stock has a market capitalization of $97.84 million, a price-to-earnings ratio of 24.91 and a beta of 0.40. AllianzIM U.S. Equity Buffer20 Nov ETF has a 12-month low of $32.83 and a 12-month high of $37.22.
AllianzIM U.S. Equity Buffer20 Nov ETF Company Profile
The Allianzim U.S. Large Cap Buffer20 Nov ETF (NVBW) is an exchange-traded fund that is based on the S&P 500 index. The fund aims for specific buffered losses and capped gains on the S&P 500 over a specific holdings period. The actively-managed fund holds options and collateral. NVBW was launched on Oct 31, 2022 and is managed by Allianz.
Recommended Stories
- Five stocks we like better than AllianzIM U.S. Equity Buffer20 Nov ETF
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for AllianzIM U.S. Equity Buffer20 Nov ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AllianzIM U.S. Equity Buffer20 Nov ETF and related companies with MarketBeat.com's FREE daily email newsletter.
